Clinical Trial

A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy Adults

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
A phase 1 study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of SRK-439 in healthy adults
Trial Details
NCT Number NCT07444294
Lead Sponsor Scholar Rock, Inc.
Conditions Healthy
Enrollment 76 participants
Start Date 2025-11-21
Primary Completion 2026-12-17 (estimated)
Study Completion 2027-06-09 (estimated)
Updated on ClinicalTrials.gov 2026-03-02